Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Leflunomide as First Line Therapy for Musculoskeletal GVHD

NCT04932564 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT04932564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04932564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Leflunomide as First Line Therapy for Musculoskeletal GVHD
Lead sponsor
Tata Memorial Centre
Phase
Phase 2
Overall status
Terminated
Start date
September 18, 2023
Completion date
June 25, 2024
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gvhd, chronic, musculoskeletal disease other